PANACEABIOPharmaceuticals
Panacea Biotec Ltd — Balance Sheet
₹296.05
-2.65%
Panacea Biotec Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 6.13 Cr | 6.13 Cr | 6.13 Cr | 6.13 Cr | — |
| Share Issued | 6.13 Cr | 6.13 Cr | 6.13 Cr | 6.13 Cr | — |
| Total Debt | 22.21 Cr | 15.00 Cr | 20.22 Cr | 34.16 Cr | — |
| Tangible Book Value | 792.53 Cr | 806.05 Cr | 817.66 Cr | 862.81 Cr | — |
| Invested Capital | 857.00 Cr | 857.05 Cr | 863.82 Cr | 910.79 Cr | — |
| Working Capital | 178.19 Cr | 176.34 Cr | 236.49 Cr | 214.18 Cr | — |
| Net Tangible Assets | 792.53 Cr | 806.05 Cr | 817.66 Cr | 862.81 Cr | — |
| Common Stock Equity | 834.79 Cr | 842.05 Cr | 843.60 Cr | 876.64 Cr | — |
| Total Capitalization | 857.00 Cr | 857.05 Cr | 863.77 Cr | 910.74 Cr | — |
| Total Equity Gross Minority Interest | 830.62 Cr | 838.23 Cr | 840.11 Cr | 873.65 Cr | — |
| Minority Interest | -4.17 Cr | -3.82 Cr | -3.49 Cr | -2.98 Cr | — |
| Stockholders Equity | 834.79 Cr | 842.05 Cr | 843.60 Cr | 876.64 Cr | — |
| Other Equity Interest | 828.66 Cr | 21.65 Cr | 21.65 Cr | 21.65 Cr | — |
| Capital Stock | 6.13 Cr | 6.13 Cr | 6.13 Cr | 6.13 Cr | — |
| Common Stock | 6.13 Cr | 6.13 Cr | 6.13 Cr | 6.13 Cr | — |
| Total Liabilities Net Minority Interest | 459.13 Cr | 402.45 Cr | 431.05 Cr | 885.21 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 92.14 Cr | 93.61 Cr | 99.22 Cr | 108.85 Cr | — |
| Other Non Current Liabilities | 10.85 Cr | 21.85 Cr | 32.14 Cr | 70.59 Cr | — |
| Non Current Deferred Taxes Liabilities | 23.28 Cr | 22.55 Cr | 20.37 Cr | 0.00 | — |
| Long Term Debt And Capital Lease Obligation | 22.21 Cr | 15.00 Cr | 20.16 Cr | 34.10 Cr | — |
| Long Term Debt | 22.21 Cr | 15.00 Cr | 20.16 Cr | 34.10 Cr | — |
| Long Term Provisions | 35.34 Cr | 27.80 Cr | 26.55 Cr | 29.16 Cr | — |
| Current Liabilities | 366.99 Cr | 308.83 Cr | 331.83 Cr | 776.37 Cr | — |
| Other Current Liabilities | 95.49 Cr | 5.26 Cr | 7.21 Cr | 320.40 Cr | — |
| Current Provisions | 36.35 Cr | 35.69 Cr | — | 12.38 Cr | 13.35 Cr |
| Payables | 225.77 Cr | 153.68 Cr | 177.32 Cr | 239.24 Cr | — |
| Total Tax Payable | 0.01 Cr | 0.13 Cr | 0.56 Cr | 0.09 Cr | — |
| Accounts Payable | 225.76 Cr | 153.68 Cr | 177.32 Cr | 234.72 Cr | — |
| Total Assets | 1.29K Cr | 1.24K Cr | 1.27K Cr | 1.76K Cr | — |
| Total Non Current Assets | 744.57 Cr | 755.49 Cr | 702.85 Cr | 768.32 Cr | — |
| Other Non Current Assets | 35.23 Cr | 61.55 Cr | 49.30 Cr | 14.74 Cr | — |
| Investmentin Financial Assets | 6.15 Cr | 1.11 Cr | 3.73 Cr | 83.66 Cr | — |
| Available For Sale Securities | 6.15 Cr | 1.04 Cr | 3.66 Cr | 83.59 Cr | — |
| Investment Properties | 15.80 Cr | 12.59 Cr | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 42.26 Cr | 36.00 Cr | 25.94 Cr | 13.82 Cr | — |
| Other Intangible Assets | 42.26 Cr | 36.00 Cr | 25.94 Cr | 13.82 Cr | — |
| Net PPE | 636.90 Cr | 636.33 Cr | 623.34 Cr | 627.67 Cr | — |
| Gross PPE | 636.90 Cr | 1.29K Cr | 1.27K Cr | 1.24K Cr | — |
| Construction In Progress | 93.51 Cr | 76.29 Cr | 35.01 Cr | 7.08 Cr | — |
| Other Properties | 543.39 Cr | 560.04 Cr | 588.33 Cr | 587.81 Cr | — |
| Current Assets | 545.18 Cr | 485.18 Cr | 568.32 Cr | 990.55 Cr | — |
| Other Current Assets | 77.26 Cr | 61.62 Cr | 56.65 Cr | 61.31 Cr | — |
| Inventory | 213.67 Cr | 177.94 Cr | 202.09 Cr | 212.72 Cr | — |
| Other Receivables | 2.57 Cr | 4.24 Cr | 2.78 Cr | 2.50 Cr | — |
| Accounts Receivable | 72.56 Cr | 57.42 Cr | 60.09 Cr | 81.66 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 179.12 Cr | 156.29 Cr | 213.05 Cr | 551.63 Cr | — |
| Other Short Term Investments | 96.99 Cr | 109.12 Cr | 173.20 Cr | 501.28 Cr | — |
| Cash And Cash Equivalents | 82.13 Cr | 47.17 Cr | 39.85 Cr | 50.35 Cr | — |
| Retained Earnings | — | 788.34 Cr | 789.85 Cr | 824.63 Cr | -254.01 Cr |
| Additional Paid In Capital | — | 194.17 Cr | 194.17 Cr | 194.17 Cr | 194.17 Cr |
| Preferred Securities Outside Stock Equity | — | 5.99 Cr | — | — | — |
| Non Current Deferred Revenue | — | 21.85 Cr | 32.14 Cr | 45.59 Cr | 2.91 Cr |
| Current Deferred Taxes Liabilities | — | 0.14 Cr | 0.56 Cr | 0.09 Cr | 0.03 Cr |
| Current Debt And Capital Lease Obligation | — | 0.00 | 0.06 Cr | 0.05 Cr | 84.45 Cr |
| Current Debt | — | 0.00 | 0.06 Cr | 0.05 Cr | 84.45 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 35.69 Cr | 36.14 Cr | 35.95 Cr | 13.35 Cr |
| Non Current Prepaid Assets | — | 61.98 Cr | 43.52 Cr | 19.41 Cr | 16.61 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | 0.07 Cr | 0.07 Cr | 0.07 Cr | 0.07 Cr |
| Accumulated Depreciation | — | -656.22 Cr | -646.89 Cr | -611.73 Cr | -570.08 Cr |
| Machinery Furniture Equipment | — | 644.15 Cr | 650.92 Cr | 651.20 Cr | 625.76 Cr |
| Buildings And Improvements | — | 319.62 Cr | 333.29 Cr | 333.29 Cr | 328.59 Cr |
| Land And Improvements | — | 252.48 Cr | 251.00 Cr | 247.83 Cr | 222.38 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Assets Held For Sale Current | — | 0.00 | 6.00 Cr | 39.99 Cr | 36.75 Cr |
| Restricted Cash | — | 28.41 Cr | 28.35 Cr | 38.99 Cr | 44.62 Cr |
| Prepaid Assets | — | 60.88 Cr | 55.95 Cr | 63.06 Cr | 67.01 Cr |
| Finished Goods | — | 46.63 Cr | 65.83 Cr | 85.45 Cr | 49.73 Cr |
| Work In Process | — | 17.48 Cr | 16.14 Cr | 30.89 Cr | 17.64 Cr |
| Raw Materials | — | 113.82 Cr | 120.12 Cr | 96.38 Cr | 106.76 Cr |
| Allowance For Doubtful Accounts Receivable | — | -4.25 Cr | -4.09 Cr | -3.90 Cr | -4.11 Cr |
| Gross Accounts Receivable | — | 61.67 Cr | 64.19 Cr | 85.56 Cr | 88.79 Cr |
| Cash Equivalents | — | 6.50 Cr | 3.62 Cr | 0.00 | — |
| Cash Financial | — | 40.67 Cr | 36.23 Cr | 50.35 Cr | 52.08 Cr |
| Other Payable | — | — | 10000.00 | 4.51 Cr | 24.83 Cr |
| Non Current Deferred Taxes Assets | — | — | 0.00 | 23.75 Cr | 0.15 Cr |
| Non Current Accrued Expenses | — | — | — | 0.00 | 191.50 Cr |
| Net Debt | — | — | — | — | 767.45 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | — | — | 55.36 Cr |
| Long Term Equity Investment | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Panacea Biotec Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.